BR100 Decreased By (-0.17%)
BR30 Decreased By (-0.43%)
KSE100 Decreased By (-0.05%)
KSE30 Increased By (0%)
AGHA 6.64 Decreased By ▼ -0.03 (-0.45%)
BECO 4.37 Increased By ▲ 0.02 (0.46%)
BML 55.11 Decreased By ▼ -1.06 (-1.89%)
BOP 29.98 Decreased By ▼ -0.14 (-0.46%)
CNERGY 12.76 Decreased By ▼ -0.22 (-1.69%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.67 Increased By ▲ 0.02 (0.04%)
FFL 14.42 Decreased By ▼ -0.07 (-0.48%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 6.02 Decreased By ▼ -0.04 (-0.66%)
KOSM 5.46 Decreased By ▼ -0.38 (-6.51%)
LOTCHEM 26.26 Increased By ▲ 0.09 (0.34%)
MLCF 91.20 Decreased By ▼ -0.03 (-0.03%)
NBP 162.20 Decreased By ▼ -1.99 (-1.21%)
NCPL 52.60 Decreased By ▼ -0.58 (-1.09%)
NPL 57.99 Decreased By ▼ -1.13 (-1.91%)
OGDC 314.96 Increased By ▲ 1.57 (0.5%)
PACE 9.75 Decreased By ▼ -0.02 (-0.2%)
PAEL 35.00 Decreased By ▼ -0.24 (-0.68%)
PIBTL 14.30 Decreased By ▼ -0.41 (-2.79%)
PPL 220.57 Decreased By ▼ -0.79 (-0.36%)
PRL 90.20 Decreased By ▼ -1.02 (-1.12%)
PTC 59.40 Increased By ▲ 0.21 (0.35%)
SSGC 23.30 No Change ▼ 0.00 (0%)
TBL 8.66 Decreased By ▼ -0.09 (-1.03%)
TELE 7.43 Decreased By ▼ -0.18 (-2.37%)
TPL 21.10 Decreased By ▼ -0.93 (-4.22%)
TPLP 12.17 Decreased By ▼ -0.39 (-3.11%)
TREET 21.51 Decreased By ▼ -0.22 (-1.01%)
TRG 54.70 Decreased By ▼ -1.09 (-1.95%)
By

UK’s FTSE 100 edged higher at open on Tuesday, led by mining and healthcare stocks, while shares of Ocado jumped after the online supermarket group kept its full-year guidance unchanged.

By 0716 GMT, the blue-chip FTSE 100 added 0.1%, while the more domestically-focussed FTSE 250 midcap index rose 0.2%.

Miners of both industrial and precious metals rose 0.5% each, as most metal prices appreciated on a softer dollar.

Ocado jumped 7.3% after the online supermarket and technology group kept its financial guidance for the year as it reported a return to underlying profit in its first half.

UK’s FTSE 100 falls as weak China data hits commodity stocks

AstraZeneca rose 0.8% after the US Food and Drug Administration (FDA) said it had approved the drugmaker and partner Sanofi’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

Darktrace jumped 20.1% after the cyber-security company said a review by auditing firm EY showed “a number of areas” where its systems, processes or controls could be improved, but added that the report will not impact its previous financial statements.

Comments

Comments are closed for this article.